ArticleOpen Access

FORMULATION ANDEVALUATION OF TRANSDERMAL DRUG DELIVERY OF TORASEMIDE

···
DOI: 10.23958/ijirms/vol01-i03/03· Pages: 80 to 89· Vol. 1, No. 03, (2016)· Published: April 25, 2016
PDF
Views: 453 PDF downloads: 181

Abstract

A skin patch uses a special membrane to control the rate at which the liquid drug contained in the reservoir within the patch can pass through the skin and into the bloodstream. The basic components of any transdermal delivery system include the drug(s) dissolved or dispersed in a reservoir or inert polymer matrix; an outer backing film of paper, plastic, or foil; and a pressure-sensitive adhesive that anchors the patch to the skin. The adhesive is covered by a release liner, which needs to be peeled off before applying the patch to the skin. Drugs administered via skin patches include scopolamine, nicotine, estrogen, nitroglycerin, and lidocaine.

Non-medicated patch markets include thermal and cold patches, nutrient patches, skin care patches (a category that consists of two major sub-categories-therapeutic and cosmetic), aroma patches, weight loss patches and patches that measure sunlight exposure.

Keywords

Torasemidesulphonyl ureanitroglycerinlidocaine
Author details
Sanjay Kumar Yadav
IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, India
✉ Corresponding Author
👤 View Profile →
Ravikant Gupta
Mylan Laboratories Ltd Indore, M.P.
👤 View Profile →🔗 Is this you? Claim this publication
S M Malipatil
HKES’s College of Pharmacy, Gulbarga, Karnataka, India
👤 View Profile →🔗 Is this you? Claim this publication
S K Gupta
Gurukul Kangri Viswavidyalaya, Haridwar, Uttaranchal
👤 View Profile →🔗 Is this you? Claim this publication